Applying multiple interventions in chronic kidney disease

被引:18
作者
Barrett, BJ
机构
[1] Mem Univ Newfoundland, Dept Med, Div Nephrol, St John, NF, Canada
[2] Mem Univ Newfoundland, Dept Med, Clin Epidemiol Unit, St John, NF, Canada
关键词
D O I
10.1046/j.1525-139X.2003.16032.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The medical, social, and financial burdens posed by end-stage renal disease (ESRD) are many and growing rapidly. People generally reach ESRD as a result of chronic progressive kidney disease. Advancing kidney disease is associated with several treatable complications, which if poorly managed reduce the length and quality of life. In addition, there are strong links between chronic kidney disease (CKD) and cardiovascular disease (CVD). Many people with less advanced CKD will die or suffer complications of CVD before reaching ESRD. Efficacious interventions, such as lowering blood pressure and treating dyslipidemia, can substantially reduce the progression of both kidney and cardiovascular disease. Careful management of these complex and interrelated diseases and risk factors requires detailed longitudinal and focused care which does not seem to be optimally delivered by health service practitioners organized in traditional ways. A disease management approach offers promise in this setting, but requires further study of clinical and economic impact.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 163 条
[51]   Effects of multidisciplinary case management in patients with chronic renal insufficiency [J].
Harris, LE ;
Luft, FC ;
Rudy, DW ;
Kesterson, JG ;
Tierney, WM .
AMERICAN JOURNAL OF MEDICINE, 1998, 105 (06) :464-471
[52]  
He J, 1999, J HYPERTENS, V17, pS7
[53]   Renoprotection: One or many therapies? [J].
Hebert, LA ;
Wilmer, WA ;
Falkenhain, ME ;
Ladson-Wofford, SE ;
Nahman, NS ;
Rovin, BH .
KIDNEY INTERNATIONAL, 2001, 59 (04) :1211-1226
[54]  
HIRSH J, 2001, GUIDELINES ANTITHROM, P49
[55]  
Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542
[56]  
HOLLAND JE, 1998, NEPHROL NEWS ISS JAN, P19
[57]   Diabetes, hemoglobin A1c, cholesterol, and the risk of moderate chronic renal insufficiency in an ambulatory population [J].
Hsu, CY ;
Bates, DW ;
Kuperman, GJ ;
Curhan, GC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (02) :272-281
[58]   Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency [J].
Hsu, CY ;
Chertow, GM ;
Curhan, GC .
KIDNEY INTERNATIONAL, 2002, 61 (05) :1567-1576
[59]   Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study [J].
Hunsicker, LG ;
Adler, S ;
Caggiula, A ;
England, BK ;
Greene, T ;
Kusek, JW ;
Rogers, NL ;
Teschan, PE .
KIDNEY INTERNATIONAL, 1997, 51 (06) :1908-1919
[60]   Excess morbidity in patients starting uremia therapy without prior care by a nephrologist [J].
Ifudu, O ;
Dawood, M ;
Homel, P ;
Friedman, EA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (06) :841-845